Send the following on WhatsApp
Continue to ChatPhase 3 Clinical Trial of COVAXIN developed by ICMR & Bharat Biotech shows 81% efficacy https://www.kamalsandesh.org/phase-3-clinical-trial-covaxin-developed-icmr-bharat-biotech-shows-81-efficacy/
Phase 3 Clinical Trial of COVAXIN developed by ICMR & Bharat Biotech shows 81% efficacy https://www.kamalsandesh.org/phase-3-clinical-trial-covaxin-developed-icmr-bharat-biotech-shows-81-efficacy/